4/25/2025 7:53:53 AM | Browse: 24 | Download: 58
| Publication Name | World Journal of Diabetes |
|---|---|
| Manuscript ID | 103244 |
| Country | United Kingdom |
|
2024-11-13 10:20 | ||
|---|---|---|---|
|
2024-11-20 01:46 | ||
|
|||
|
2025-02-12 02:05 | ||
|
2025-02-12 21:42 | ||
|
2025-02-25 02:45 | ||
|
|||
|
2025-02-25 08:27 | ||
|
2025-02-25 08:27 | ||
|
|||
|
2025-03-02 21:00 | ||
|
2025-04-09 01:58 | ||
|
2025-04-25 07:53 |
| ISSN | 1948-9358 (online) |
|---|---|
| Open Access | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright | © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247 |
| Permissions | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 |
| Publisher | Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website | http://www.wjgnet.com |
| Category | Endocrinology & Metabolism | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Manuscript Type | Systematic Reviews | ||||||||||||||
| Article Title | Effect of Beinaglutide, a thrice-daily GLP-1 receptor agonist, on body weight and metabolic parameters: A systematic review | ||||||||||||||
| Manuscript Source | Invited Manuscript | ||||||||||||||
| All Author List | Abul Bashar Mohammad Kamrul-Hasan, Vanishri Ganakumar, Lakshmi Nagendra, Deep Dutta, M Rafiqul Islam and Joseph M Pappachan | ||||||||||||||
| ORCID |
|
||||||||||||||
| Funding Agency and Grant Number | |||||||||||||||
| Corresponding Author | Joseph M Pappachan, MD, Professor, Senior Researcher, Faculty of Science,, Manchester Metropolitan University, Manchester, Manchester M15 6BH, United Kingdom. drpappachan@yahoo.co.in | ||||||||||||||
| Key Words | Meta-analysis; Weight reduction; Type 2 diabetes; Obesity; Glucagon-like polypeptide-1 receptor agonist; Beinaglutide | ||||||||||||||
| Core Tip | This systematic review assessed available randomized controlled trials involving patients receiving Beinaglutide, a short-acting glucagon-like polypeptide-1 receptor agonist, in the intervention arm and either a placebo or an active comparator in the control arm. Beinaglutide at doses of 0.1-0.2 mg three times daily for 12-24 weeks was more effective than the control group at reducing body weight. Beinaglutide also demonstrated superiority over the control group in reducing BMI and waist circumference. Beinaglutide posed greater risks of treatment discontinuation due to adverse events, including nausea, vomiting, palpitations, headaches, and dizziness, compared to the control group. However, the two groups had identical risks of total and serious adverse events, diarrhea, fatigue, and hypoglycemia. | ||||||||||||||
| Publish Date | 2025-04-25 07:53 | ||||||||||||||
| Citation | <p>Kamrul-Hasan ABM, Ganakumar V, Nagendra L, Dutta D, Islam MR, Pappachan JM. Effect of Beinaglutide, a thrice-daily GLP-1 receptor agonist, on body weight and metabolic parameters: A systematic review. <i>World J Diabetes</i> 2025; 16(5): 103244</p> | ||||||||||||||
| URL | https://www.wjgnet.com/1948-9358/full/v16/i5/103244.htm | ||||||||||||||
| DOI | https://dx.doi.org/10.4239/wjd.v16.i5.103244 |
| Full Article (PDF) | WJD-16-103244-with-cover.pdf |
|---|---|
| PRISMA 2009 Checklist | 103244-PRISMA-2009-Checklist.pdf |
| Manuscript File | 103244_Auto_Edited_074019.docx |
| Answering Reviewers | 103244-answering-reviewers.pdf |
| Audio Core Tip | 103244-audio.m4a |
| Biostatistics Review Certificate | 103244-biostatistics-statement.pdf |
| Conflict-of-Interest Disclosure Form | 103244-conflict-of-interest-statement.pdf |
| Copyright License Agreement | 103244-copyright-assignment.pdf |
| Supplementary Material | 103244-supplementary-material.pdf |
| Peer-review Report | 103244-peer-reviews.pdf |
| Scientific Misconduct Check | 103244-scientific-misconduct-check.png |
| Scientific Editor Work List | 103244-scientific-editor-work-list.pdf |
| CrossCheck Report | 103244-crosscheck-report.png |
| CrossCheck Report | 103244-crosscheck-report.pdf |